Enveric Biosciences updates Lind Group ownership stake

Enveric Biosciences, Inc. received an updated Schedule 13G/A from Lind Global Fund III LP, Lind Global Partners III LLC, and Jeff Easton reporting their beneficial ownership through Series G Warrants to purchase common stock.

Rhea-AI Filing Summary

Enveric Biosciences, Inc. received an updated Schedule 13G/A from Lind Global Fund III LP, Lind Global Partners III LLC, and Jeff Easton reporting their beneficial ownership through Series G Warrants to purchase common stock. Each reporting person now reports beneficial ownership of 1.3%–1.4% of Enveric's common stock, all below 5% of the class.

The filing notes that 49,366–51,866 Series G Warrants are held across the reporting persons, with sole voting and dispositive power and no shared power reported. The Series G Warrants include a 9.99% beneficial ownership limitation, restricting conversions that would result in ownership above that threshold.

Key Figures

Lind Global Fund III beneficial ownership: 49,366 Series G Warrants; 1.3% Lind Global Partners III beneficial ownership: 49,366 Series G Warrants; 1.3% Jeff Easton beneficial ownership: 51,866 Series G Warrants; 1.4% +2 more

5 metrics

Lind Global Fund III beneficial ownership 49,366 Series G Warrants; 1.3% Beneficial ownership of Enveric common stock reported by Lind Global Fund III LP

Lind Global Partners III beneficial ownership 49,366 Series G Warrants; 1.3% Beneficial ownership of Enveric common stock reported by Lind Global Partners III LLC

Jeff Easton beneficial ownership 51,866 Series G Warrants; 1.4% Beneficial ownership of Enveric common stock reported by Jeff Easton

Beneficial ownership limitation 9.99% Series G Warrants cannot be converted if it causes ownership above this threshold

Ownership threshold statement 5 percent or less Reporting persons disclose ownership of 5 percent or less of the class

Key Terms

beneficially own, Series G Warrants, Sole Voting Power, dispositive power, +1 more

5 terms

beneficially own financial

"limiting the holder's ability to convert the Series G Warrants if such conversion would cause the holder to beneficially own greater than 9.99%"

Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.

Series G Warrants financial

"The reporting person's ownership consists of 49,366 warrants to purchase shares of common stock (the "Series G Warrants")"

A Series G warrant is a specific batch of warrants — financial instruments that give the holder the right, but not the obligation, to buy a company’s stock at a set price before a deadline. Think of it like a ticket that lets you lock in today’s price for a future purchase; investors care because exercise can dilute existing shares or provide a way to profit if the stock rises above the ticket price, affecting a company’s value and shareholder returns.

Sole Voting Power financial

"5 | Sole Voting Power 49,366.00 6 | Shared Voting Power 0.00"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

dispositive power financial

"7 | Sole Dispositive Power 49,366.00 8 | Shared Dispositive Power 0.00"

Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.

beneficial ownership limitation financial

"The Series G Warrants include a provision limiting the holder's ability to convert"

A beneficial ownership limitation is a rule that caps the percentage of a company’s shares an investor can be treated as owning or controlling for voting, regulatory or tax purposes. It matters to investors because it can restrict how many shares a person or group can buy or vote, affect takeover chances, and influence share liquidity and value — like a speed limit that prevents any single driver from taking over the whole road.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What ownership in ENVB does Lind Global Fund III report in this Schedule 13G/A?

Lind Global Fund III reports beneficial ownership of 49,366 Series G Warrants, representing 1.3% of Enveric Biosciences' common stock. These warrants provide sole voting and dispositive power, with no shared power reported for the position.

What does Jeff Easton report as his beneficial ownership in ENVB?

Jeff Easton reports beneficial ownership of 51,866 Series G Warrants, equal to 1.4% of Enveric Biosciences' common stock. This includes warrants held by Lind Global Fund III and Lind Global Fund II, all with sole voting and dispositive power.

Why does the ENVB filing state ownership of 5 percent or less?

The filing states that the reporting persons own 5 percent or less of Enveric's common stock. Their reported stakes range from 1.3% to 1.4%, which places each reporting person below the 5% ownership threshold for this security class.

What is the 9.99% beneficial ownership limitation mentioned for ENVB warrants?

The Series G Warrants include a clause preventing conversion if it would cause the holder to beneficially own more than 9.99% of Enveric's common stock. This provision caps potential post-conversion ownership from these warrants at that level.

Which entities are the reporting persons in Enveric Biosciences (ENVB)'s Schedule 13G/A?

The reporting persons are Lind Global Fund III LP, Lind Global Partners III LLC, and Jeff Easton. Lind Global Partners III LLC is the general partner of the fund, and Jeff Easton is the managing member with deemed voting and dispositive power.

Where are the ENVB reporting persons based according to this ownership filing?

All reporting persons list their principal business office at 444 Madison Ave, Floor 41, New York, NY 10022. Lind Global Fund III LP and Lind Global Partners III LLC are organized in Delaware; Jeff Easton is a citizen of the United States.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/14/2026 - 04:17 PM Accepted by SEC EDGAR 08/14/2026 - 04:08 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 2)

Enveric Biosciences, Inc.

(Name of Issuer)

Common Stock, $0.01 par value

(Title of Class of Securities)

29405E505

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 29405E505

1

Names of Reporting Persons

Lind Global Fund III LP

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 49,366.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 49,366.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

49,366.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

1.3 %

12

Type of Reporting Person (See Instructions)

PN

Comment for Type of Reporting Person: (1) The reporting person's ownership consists of 49,366 warrants to purchase shares of common stock (the "Series G Warrants"). (2) The Series G Warrants include a provision limiting the holder's ability to convert the Series G Warrants if such conversion would cause the holder to beneficially own greater than 9.99% of the Company.

SCHEDULE 13G

CUSIP Number(s): 29405E505

1

Names of Reporting Persons

Lind Global Partners III LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 49,366.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 49,366.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

49,366.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

1.3 %

12

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person: (1) The reporting person's ownership consists of 49,366 Series G Warrants. (2) The Series G Warrants include a provision limiting the holder's ability to convert the Series G Warrants if such conversion would cause the holder to beneficially own greater than 9.99% of the Company.

SCHEDULE 13G

CUSIP Number(s): 29405E505

1

Names of Reporting Persons

EASTON JEFF

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 51,866.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 51,866.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

51,866.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

1.4 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: (1) The reporting person's ownership consists of 51,866 Series G Warrants held by Lind Global Fund III to purchase shares of common stock, and (iii) 2,500 warrants held by Lind Global Fund II to purchase shares of common stock. (2) The Series G Warrants include a provision limiting the holder's ability to convert the Series G Warrants if such conversion would cause the holder to beneficially own greater than 9.99% of the Company.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Enveric Biosciences, Inc.
(b)	Address of issuer's principal executive offices: 245 First Street, Riverview II, 18th Floor, Cambridge, Massachusetts, 02142
Item 2.
(a)	Name of person filing: This statement is filed by the following entities and individuals (collectively, referred to as the "Reporting Persons"): o Lind Global Fund III LP, a Delaware limited partnership; o Lind Global Partners III LLC, a Delaware limited liability company; and o Jeff Easton, an individual and a citizen of the United States of America. Lind Global Partners III LLC, the general partner of Lind Global Fund III LP, may be deemed to have sole voting and dispositive power with respect to the shares held by Lind Global Fund III LP. Jeff Easton, the managing member of Lind Global Partners III LLC, may be deemed to have sole voting and dispositive power with respect to the shares held by Lind Global Fund III LP.
(b)	Address or principal business office or, if none, residence: The address of the principal business office for each of the Reporting Persons is: 444 Madison Ave, Floor 41 New York, NY 10022
(c)	Citizenship: See Row 4 of cover page for each Reporting Person.
(d)	Title of class of securities: Common Stock, $0.01 par value
(e)	CUSIP No.: 29405E505
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: See Row 9 of cover page for each Reporting Person.
(b)	Percent of class: See Row 11 of cover page for each Reporting Person.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See Row 5 of cover page for each Reporting Person.
	(ii) Shared power to vote or to direct the vote: See Row 6 of cover page for each Reporting Person.
	(iii) Sole power to dispose or to direct the disposition of: See Row 7 of cover page for each Reporting Person.
	(iv) Shared power to dispose or to direct the disposition of: See Row 8 of cover page for each Reporting Person.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Lind Global Fund III LP

Signature:	By: Lind Global Partners III LLC, its General Partner, By: /s/ Jeff Easton
Name/Title:	Jeff Easton, Managing Member
Date:	08/14/2026

Lind Global Partners III LLC

Signature:	/s/ Jeff Easton
Name/Title:	Jeff Easton, Managing Member
Date:	08/14/2026

EASTON JEFF

Signature:	/s/ Jeff Easton
Name/Title:	Jeff Easton
Date:	08/14/2026